187 related articles for article (PubMed ID: 37563745)
1. Improving statins production: From non-genetic strategies to genetic strategies.
Fan D; Tang H; Yang X; Zhao F; Han S
Biotechnol J; 2023 Dec; 18(12):e2300229. PubMed ID: 37563745
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
Manzoni M; Rollini M
Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
[TBL] [Abstract][Full Text] [Related]
3. Biotechnological Production of Statins: Metabolic Aspects and Genetic Approaches.
Neto RNM; de Barros Gomes E; Weba-Soares L; Dias LRL; da Silva LCN; de Miranda RCM
Curr Pharm Biotechnol; 2019; 20(15):1244-1259. PubMed ID: 31333127
[TBL] [Abstract][Full Text] [Related]
4. Emerging approaches in fermentative production of statins.
Singh SK; Pandey A
Appl Biochem Biotechnol; 2013 Oct; 171(4):927-38. PubMed ID: 23912209
[TBL] [Abstract][Full Text] [Related]
5. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Moghadasian MH
Life Sci; 1999; 65(13):1329-37. PubMed ID: 10503952
[TBL] [Abstract][Full Text] [Related]
8. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
Evans M; Rees A
Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
10. Engineering Robustness of Microbial Cell Factories.
Gong Z; Nielsen J; Zhou YJ
Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28857502
[TBL] [Abstract][Full Text] [Related]
11. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
12. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant effects of statins.
Stoll LL; McCormick ML; Denning GM; Weintraub NL
Drugs Today (Barc); 2004 Dec; 40(12):975-90. PubMed ID: 15645009
[TBL] [Abstract][Full Text] [Related]
14. Statins as anti-inflammatory agents.
Weitz-Schmidt G
Trends Pharmacol Sci; 2002 Oct; 23(10):482-6. PubMed ID: 12368073
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
[TBL] [Abstract][Full Text] [Related]
16. One statin, two statins, three statins, more: similarities and differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Turkoski BB
Orthop Nurs; 2011; 30(1):62-5; quiz 66-7. PubMed ID: 21278557
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy in cardiovascular diseases other than atherosclerosis.
Beaudry D; Stone KE; Wetherold S; Hemphill J; Do D; McClish J; Chilton R
Curr Atheroscler Rep; 2007 Jan; 9(1):25-32. PubMed ID: 17228487
[TBL] [Abstract][Full Text] [Related]
19. Biotechnological advantages of laboratory-scale solid-state fermentation with fungi.
Hölker U; Höfer M; Lenz J
Appl Microbiol Biotechnol; 2004 Apr; 64(2):175-86. PubMed ID: 14963614
[TBL] [Abstract][Full Text] [Related]
20. Enhanced production of Lovastatin by filamentous fungi through solid state fermentation.
Kamal S; Akhter N; Khan SG; Kiran S; Farooq T; Akram M; Shah SMA; Tahir IM; Akhlaq M; Said F; Zaheer J
Pak J Pharm Sci; 2018 Jul; 31(4(Supplementary)):1583-1589. PubMed ID: 30058552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
